腫瘍病理鑑別診断アトラス　胆道癌・膵癌

出版社： 文光堂
著者：
発行日： 2015-04-16
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622472
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2015-04-16 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

19,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

19,800 円(税込)

購入する

商品紹介

診断と治療の発展が目覚しい，胆道癌・膵癌分野の病理診断を明快に解説したガイドブック．全国で標準化・均霑化された病理診断が行われ，適切な診療に反映されるための成書．

目次

  • 胆道癌・膵癌

    ―目次―

    第１部　検鏡前の確認事項
    　I．胆道・膵腫瘍組織分類の現状：
    　　　癌取扱い規約とWHO分類の概要と相違
    　　１．胆道腫瘍
    　　２．膵腫瘍
    　II．病理標本の取り扱い方
    　　１．生検，細胞診標本
    　　２．手術切除標本
    　III．胆道・膵腫瘍の肉眼所見
    　IV．胆道腫瘍診断に有用な免疫組織化学
    　V．膵腫瘍診断に有用な免疫組織化学，遺伝子検査

    第２部　組織型と診断の実際
    　?．胆道病変
    　　１．腫瘍様病変（ポリープを含む）および腺筋腫症
    　　２．胆道癌の前癌病変（IPNB，BilIN，ICPN を含む）
    　　３．胆道癌腺癌および稀な上皮性腫瘍
    　　４．神経内分泌腫瘍（NET）および
    　　　　　関連腫瘍（パラガングリオーマを含む）
    　　５．稀な非上皮性腫瘍および腫瘍様病変
    　　６．胆管の炎症性疾患：PSC，IgG4関連硬化性胆管炎
    　　７．胆?の炎症性疾患（黄色肉芽腫性胆?炎を含む）
    　II．膵病変
    　　１．漿液性腫瘍
    　　２．粘液性?胞腫瘍（MCN）
    　　３．膵管内腫瘍（IPMN，ITPN）
    　　４．浸潤性膵管癌（亜型，前駆病変を含む）
    　　５．腺房細胞癌
    　　６．神経内分泌腫瘍
    　　７．solid pseudopapillary neoplasm（SPN）
    　　８．稀な膵腫瘍-非上皮性腫瘍，腫瘍様病変
    　　９．転移性膵癌
    　　10．自己免疫性膵炎

    第３部　鑑別ポイント
    　?．膵癌の胆管浸潤 vs 胆管癌の膵浸潤
    　II．管内発育型胆管癌 vs IPNB vs BilIN
    　III．乳頭部腺腫 vs 早期乳頭部癌
    　IV．PanIN vs IPMN
    　V．膵管内乳頭粘液性腫瘍（IPMN）由来癌 vs
    　　　通常型膵癌 vs 併存癌
    　VI．生検による鑑別診断アプローチ
    　VII．胆汁，膵液，FNAを含めた細胞診における鑑別診断
    　VIII．術中迅速診断における鑑別，判定，報告（細胞診の併用）
    　　１．胆道
    　　２．膵

    第４部　臨床との連携
    　?．画像診断の病理への応用
    　II．胆膵領域の内視鏡診断
    　III．胆道癌・膵癌の進行度と治療方針・予後
    　IV．胆道癌・膵癌の進展度診断と断端評価
    　V．診療ガイドラインで問われる病理関連事項
    　　１．胆道
    　　２．膵
    　VI．組織学的治療効果判定
    　VII．病理診断報告書の記載
    　　１．生検，切除検体
    　　２．細胞診

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.7 掲載の参考文献
1) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
2) 日本胆道外科研究会編 : 外科・病理 胆道癌取扱い規約, 第5版, 金原出版, 2009
 
3) Sobin LH, Gospodarowicz MK, Wittekind CH eds : TNM Classification of Malignant Tumours (UICC), 7th ed, Wiler-Liss, New York, 2009, pp118-131 (Gallbladder, Extrahepatic Bile Duct-perihilar/distal, Ampullary of Vater)
 
4) Bosmann FT, Carneiro F, Hruban HR, et al eds : WHO Classification of Tumours of the Digestive System, IARC Press, Lyon, 2010, pp263-278 (Chapter 11, Tumours of the Gallbladder and Extrahepatic Bile Duct)
 
5) Hamilton SR, Aaltonen LA eds : Pathology and Genetics of Tumours of the Digestive System, World Health Organization Classification of Tumours, IARC Press, Lyon, 2000, pp203-214 (Chapter 9, Tumours of the Gallbladder and Extrahepatic Bile Duct)
 
6) Albores-Saavedra J, Henson DE, Klimstra DS : Tumors of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Atlas of tumor pathology. 3rd series, fascicle 27. Armed Forces Institute of Pathology (AFIP), Washington DC, 1998
 
7) Zen Y, Fujii T, Itatsu K et al : Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 44 : 1333-1343, 2006
PubMed
8) Adsay V, Jang KT, Roa JC, et al : Intracholecystic papillarytubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillar y neoplasms that are > 1.0cm) : clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol 36 : 1279-1301, 2012
 
9) Zen Y, Aishima S, Ajioka Y, et al : Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma : preliminary report based on interobserver agreement. Pathol Int 55 : 180-188, 2005
PubMed
10) 佐藤保則, 中沼安二 : 胆管内腫瘍の組織分類とそのエビデンス. 胆と膵 32 : 1331-1338, 2011
Medical*Online
11) Zen Y, Adsay NV, Bardadin K, et al : Biliary intraepithelial neoplasia : an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 20 : 701-709, 2007
PubMed
12) 鬼島宏 : 胆嚢・胆管. 向井清, 真鍋俊明, 深山正久編 : 外科病理学, 第4版, 文光堂, pp665-698, 2006
 
13) 日本肝胆膵外科学会 胆道癌診療ガイドライン作成委員会編 : 胆道癌診療ガイドライン, 改訂第2版, 医学図書出版, 2014
 
P.13 掲載の参考文献
1) Bosman FT, Carneiro F, Hruban RH, et al eds : WHO Classification of Tumours of the Digestive System (4th ed.), IARC Press, Lyons France, 2010, pp10-12
 
2) 日本膵臓学会編 : 膵癌取扱い規約, 第6版補訂版, 金原出版, 2013
 
3) Yamaguchi H, Shimizu M, Ban S et al : Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 33 : 1164-1172, 2009
PubMed
4) Hruban RH, Adsay NV, Albores-Saavedra J et al : Pancreatic intraepithelial neoplasia : a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25 : 579-586, 2001
PubMed
5) Agaimy A, Haller F, Frohnauer J et al : Pancreatic undifferentiated rhabdoid carcinoma : KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol 28 : 248-260, 2015
PubMed
6) Singhi AD, Norwood S, Liu TC et al : Acinar cell cystadenoma of the pancreas : a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium? Am J Surg Pathol 37 : 1329-1335, 2013
PubMed
P.19 掲載の参考文献
1) Yamao K, Sawaki A, Mizuno N et al : Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUSFNAB) : past, present, and future. J Gastroenterol 40 : 1013-1023, 2005
PubMed
2) Hartwig W, Schneider L, Diener MK et al : Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg 96 : 5-20, 2009
PubMed
3) 山雄健次, 入澤篤志編 : EUS下穿刺術-Interventional EUSの基礎と実践テクニック-, 南江堂, 2011, pp7-11
 
4) 三宅康 : 技術講座 セルブロック作製法. Medical Technology 32 : 187-195, 2004
 
5) Orell SR, Sterrett GF : Orell and Sterrett's Fine Needle Aspiration Cytology (5th ed.), Churchill Livingstone, New York, 2011, p15
 
6) 松永徹, 羽場礼次 : 細胞診およびセルブロックへの応用 体腔液, 穿刺細胞診を中心に. 免疫組織化学. 病理と臨床 32 (臨増) : 45-53, 2014
 
7) 佐野順司, 吉本尚子, 溝口良順他 : アルギン酸ナトリウムを用いたセルブロック法の有用性についての検討. 日臨細胞会誌 44 : 291-297, 2005
 
8) Hosoda W, Takagi T, Mizuno N et al : Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration. Pathol Int 60 : 358-364, 2010
PubMed
9) Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I et al : Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol 106 : 1705-1710, 2011
 
10) Haba S, Yamao K, Bhatia V et al : Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions : Japanese large single center experience. J Gastroenterol 48 : 973-981, 2013
PubMed
11) 丸田淳子, 橋本信裕, 山下裕人他 : 改良Ultrafast Papanicolaou染色を用いた甲状腺迅速細胞診. 日臨細胞会誌 42 : 212-217, 2003
 
12) 森本利昭, 高橋保, 植田庄介他 : ベッドサイド細胞診の実際と意義. 病理と臨床 23 : 600-604, 2005
 
13) 若狭朋子, 稲山久美子, 若狭研一他 : 胆膵共通疾患とトピックス 胆膵領域の細胞診EUS-FNA を含めて. 病理と臨床 31, 388-393, 2013
 
14) de Bellis M, Sherman S, Fogel EL et al : Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc 56 : 720-730, 2002
PubMed
P.28 掲載の参考文献
1) 病理と臨床常任編集委員会編 : 外科病理マニュアル. 病理と臨床 26 (臨増), 2008
 
2) 日本胆道外科研究会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
3) 福嶋敬宜, 二村聡編 : 臨床に活かす病理診断学. 消化管・肝胆膵編, 第2版, 医学書院, 2011
 
4) 日本膵癌研究会編 : 臨床・病理 膵がん取扱い規約, 第6版補訂版, 金原出版, 2009
 
5) Campbell F, Verbeke CS, eds : Pathology of the pancreas, A practical approach, Springer-Verlag, London, 2013
 
P.42 掲載の参考文献
1) 日本膵臓学会編 : 膵癌取扱い規約, 第6版補訂版, 金原出版, 2013
 
2) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
3) Bosman FT, Arneiro F, Hruban RH et al (eds) : WHO Classification, Tumours of the Digestive System, 4th ed, IARC Press, Lyon, 2010
 
4) Albores-Saavedra J, Henson DE, Klimstra DS : Atlas of tumor pathology, Third series. Fascicle 27, Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, AFIP, Washington DC, 2000, pp259-316
 
P.47 掲載の参考文献
1) Tamada S, Goto M, Nomoto M et al : Expression of MUC1 and MIC2 mucins in extrahepatic bile duct carcinomas : its relationship with tumor progression and prognosis. Pathol Int 52 : 713-723, 2002
 
2) Zen Y, Quaglia A, Heaton N et al : Two distinct pathways of carcinogenesis in primary sclerosing cholangitis. Histopathology 59 : 1100-1110, 2011
PubMed
3) Albores-Saavedra J, Chable-Montero F, Mendez-Sanchez N et al : Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts : a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma. Hum Pathol 43 : 2292-2298, 2012
PubMed
4) Aishima S, Kuroda Y, Nishihara Y et al : Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma : gastric foveolar type is associated with aggressive tumour behaviour. Histopathology 49 : 35-44, 2006
PubMed
5) Shibahara H, Tamada S, Higashi M et al : MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 39 : 220-229, 2004
PubMed
6) Albores-Saavedra J, Batich K, Hossain S et al : Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts : a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Ann Diagn Pathol 13 : 378-383, 2009
PubMed
7) Nakashima H, Nagafuchi K, Satoh H et al : Hepatoid adenocarcinoma of the gallbladder. J Hepatobiliary Pancreat Surg 7 : 226-230, 2000
PubMed
8) Levy M, Lin F, Xu H et al : S-100P, von-Hipple-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol 41 : 1210-1219, 2010
 
9) Aishima S, Fujita N, Mano Y et al : Different roles of S-100P overexpression in intrahepatic cholangiocarcinoma : carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol 35 : 590-598, 2011
 
10) Eguchi T, Inoue T, Fujii K et al : Laminin-5 (gamma2 chain) is a marker of invading cancer cells in human gallbladder carcinoma : special emphasis on extension of carcinoma in situ along Rokitansky-Aschoff sinuses. Oncol Rep 20 : 33-39, 2008
PubMed
11) Zhang L, Frank R, Furth EE et al : Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Exp Hematol Oncol 3 : 12, 2014
PubMed
12) Surrey LF, Frank R, Zhang PJ et al : TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts : continued caveats for utilization of immunohistochemistry panels. Am J Surg Pathol 38 : 224-227, 2014
 
P.53 掲載の参考文献
1) Furukawa T, Kloppel G, Volkan Adsay N et al : Classification of types of intraductal papillary-mucinous neoplasm of the pancreas : a consensus study. Virchows Arch 447 : 794-799, 2005
PubMed
2) Yamaguchi H, Shimizu M, Ban S et al : Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 33 : 1164-1172, 2009
PubMed
3) Hoorens A, Lemoine NR, McLellan E et al : Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 143 : 685-698, 1993
PubMed
4) Klimstra DS, Heffess CS, Oertel JE et al : Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 16 : 815-837, 1992
PubMed
5) La Rosa S, Franzi F, Marchet S et al : The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch 454 : 133-142, 2009
PubMed
6) Goggins M, Offerhaus GJ, Hilgers W et al : Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 152 : 1501-1507, 1998
PubMed
7) Perez-Ordonez B, Naseem A, Lieberman PH et al : Solid serous adenoma of the pancreas. The solid variant of serous cystadenoma? Am J Surg Pathol 20 : 1401-1405, 1996
PubMed
8) Reese SA, Traverso LW, Jacobs TW et al : Solid serous adenoma of the pancreas : a rare variant within the family of pancreatic serous cystic neoplasms. Pancreas 33 : 96-99, 2006
PubMed
9) Tanaka Y, Kato K, Notohara K et al : Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 61 : 8401-8404, 2001
PubMed
10) Adsay NV, Fukushima N, Furukawa T et al : Intraductal neoplasms of the pancreas. in FT Bosman, RH Hruban, F Carneiro et al (eds) : "WHO Classification of Tumours of the Digestive System", IARC, Lyon, 2010, pp304-313
 
11) Xiao HD, Yamaguchi H, Dias-Santagata D et al : Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol 224 : 508-516, 2011
PubMed
12) Furukawa T, Hatori T, Fujita I et al : Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 60 : 509-516, 2011
PubMed
13) Yamaguchi H, Kuboki Y, Hatori T et al : Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Surg Pathol 35 : 1812-1817, 2011
PubMed
14) Kuboki Y, Shiratori K, Hatori T et al : Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas. Mod Pathol 23 : 1127-1135, 2010
PubMed
15) Gibbs JB, Sigal IS, Poe M et al : Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc Natl Acad Sci USA 81 : 5704-5708, 1984
PubMed
16) Yanagisawa A, Ohtake K, Ohashi K et al : Frequent c-Kiras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 53 : 953-956, 1993
 
17) Pietenpol JA, Tokino T, Thiagalingam S et al : Sequencespecific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci USA 91 : 1998-2002, 1994
PubMed
18) Furukawa T, Fujisaki R, Yoshida Y et al : Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol 18 : 1034-1042, 2005
PubMed
19) Nakamori S, Yashima K, Murakami Y et al : Association of p53 gene mutations with short survival in pancreatic adenocarcinoma. Jpn J Cancer Res 86 : 174-181, 1995
PubMed
20) Shioda T, Lechleider RJ, Dunwoodie SL et al : Transcriptional activating activity of Smad4 : roles of SMAD heterooligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci USA 95 : 9785-9790, 1998
PubMed
21) Wu J, Matthaei H, Maitra A et al : Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 3 : 92ra66, 2011
PubMed
22) Furukawa T, Kuboki Y, Tanji E et al : Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1 : 161, 2011
PubMed
23) Wu J, Jiao Y, Dal Molin M et al : Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci USA 108 : 21188-21193, 2011
PubMed
24) Goggins M, Schutte M, Lu J et al : Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56 : 5360-5364, 1996
PubMed
25) Chmielecki J, Hutchinson KE, Frampton GM et al : Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes. Cancer Discov 4 : 1398-1405, 2014
PubMed

第2部 組織型と診断の実際

P.64 掲載の参考文献
1) Duarte I, Llanos O, Domke H et al : Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer 75 : 1878-1884, 1993
 
2) Yamagiwa H, Tomiyama H : Intestinal metaplasia-dysplasia-carcinoma sequence of the gallbladder. Acta Pathol Jpn 36 : 989-997, 1986
PubMed
3) 鬼島宏, 渡辺英伸, 長村義之 : 胆道上皮の化生性変化と前癌病変の病理. 病理と臨床 21 : 31-41, 2003
Medical*Online
4) 鬼島宏, 渡辺英伸, 白井良夫他 : 隆起性病変の病理学. 消化器科 17 : 96-103, 1992
 
5) 武藤良弘, 内山正行, 脇慎治他 : 胆嚢adenomyomatosis (locarized type) 37症例の臨床病理. 日消誌 75 : 1756-1767, 1978
 
6) Jutras JA : Hyperplastic cholecystoses : Hickey lecture. Am J Roentgenol Radium Ther Nucl Med 83 : 795-827, 1960
PubMed
7) Albores-Saavedra J, Langels-Angeles A : Disease of the Gallbladder. in Burt A, Portman B, Ferrell L (eds) : "Mac-Sween's Pathology of the Liver", Churchill livingstone, 6th ed, Edinburg, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto, 2011, pp563-597
 
8) Kurihara K, Mizuseki K, Ninomiya T et al : Carcinoma of the gall-bladder arising in adenomyomatosis. Acta Pathol Jpn 43 : 82-85, 1993
PubMed
9) Katoh T, Nakaki T, Hayashi S et al : Noninvasive carcinoma of the gallbladder arising in localized type adenomyomatosis. Am J Gastroenterol 83 : 670-674, 1988
 
10) Ootani T, Shirai Y, Tsukada K et al : Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer 69 : 2647-2652, 1992
PubMed
11) 鬼島宏, 渡辺英伸, 長村義之 : 胆嚢癌早期病変の病理. 胆と膵 23 : 257-265, 2002
Medical*Online
12) Kijima H, Watanabe H, Iwafuchi M et al : Histogenesis of gallbladder carcinoma from investigation of early carcinoma and microcarcinoma. Acta Pathol Jpn 39 : 235-244, 1989
PubMed
13) 鬼島宏, 羽賀敏博, 高綱将史 他 : 胆嚢癌の前癌病変. 日消誌 112 : 437-443, 2015
Medical*Online
14) 鬼島宏 : 胆嚢・胆管. 向井清, 真鍋俊明, 深山正久編 : 外科病理学, 第4版, 文光堂, 2006, pp665-698
 
P.74 掲載の参考文献
1) Odze RD, Riddell RH, Bosman FT et al : Premalignant lesions of the digestive system. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO classification of Tumours of the Digestive System", I ARC Press, 2010, pp10-12
 
2) 日本肝胆膵外科学会 (編) : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
3) Nakanuma Y, Terada T, Tanaka Y et al : Are hepatolothiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchow Arch A Pathol Anat Histopathol 406 : 45-58, 1985
 
4) Nakanuma Y, Sripa B, Vatanasapt V : Intrahepatic cholangiocarcinoma. in Hamilton SR, Aaltonen LA (eds) : "WHO Classification of Tumours. Pathology & Genetics Tumours of the Digestive System", IARC Press, 2000, pp173-180
 
5) Zen Y, Adsay NV, Bardadin K et al : Biliary intraepithelial neoplasia : an international interobserver agreement study and proposal for diagnostic criteria. Modern Pathol 20 : 701-709, 2007
 
6) 全陽 : Biliary intraepithelial neoplasia (BilIN). 中沼安二, 坂元亨宇編 : 腫瘍病理鑑別診断アトラス 肝癌, 文光堂, 2010, pp97-101
 
7) Aishima S, Fujita N : Different roles of S100P overexpression in intrahepatic cholangiocarcinoma : carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg pathol 35 : 590-598, 2011
PubMed
8) Iguchi T, Aishima S : Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma ; immunohistochemical and molecular analysis. Hum Pathol 40 : 174-180, 2009
PubMed
9) Nakanishi Y, Zen Y : Expression of cell-cycle-related molecules in biliary premalignant lesions : biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol 39 : 1153-1161, 2008
PubMed
10) Kim HJ, Kim MH, Lee SK et al : Mucin hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy 32 : 389-393, 2000
PubMed
11) Chen TC, Nakanuma Y, Zen Y et al : Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 34 : 651-658, 2001
PubMed
12) Shimonishi T, Zen Y, Chen TC et al : Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol 33 : 503-511, 2002
PubMed
13) Abraham SC, Lee JH : Microsatellite instability in intraductal papillary neoplasms of the biliary tract. Mod Pathol 15 : 1309-1317, 2002
PubMed
14) J Rocha FG, Lee H, Katabi N et al : Intraductal papillary neoplasm of the bile duct : a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 56 : 1352-1360, 2012
 
15) Shibahara H, Tamada S : Pathologic features of mucinproducing bile duct tumors : two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 28 : 327-338, 2004
PubMed
16) 柴原弘明, 米澤傑 : ムチン蛋白発現からみた粘液産生胆道腫瘍の膵IPMNとの対比. 胆と膵 27 : 451-457, 2006
 
17) Albores-Saavedra J, Chable-Montero F, MA Gonzalez-Romo et al : Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia/carcinoma in situ and invasive carcinoma. Human Pathology 43 : 1506-1513, 2012
 
18) Adsay V, Jang KT, Roa JC et al : Intracholecystic papillarytubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≧ 1.0cm) Clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol 36 : 1279-1301, 2012
 
19) Adsay V, Ohike N, Tajiri T et al : Ampullary region carcinomas : definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol 36 : 1592-1608, 2012
 
20) Ohike N, Kim GE, Tajiri T et al : Intra-ampullary papillary-tubular neoplasm (IAPN) : characterization of tumoral intraepithelial neoplasia occurring within the ampulla : a clinicopathologic analysis of 82 cases. Am J Surg Pathol 34 : 1731-1748, 2010
PubMed
P.85 掲載の参考文献
1) Bosman FT, Carneiro F, Hruban RH et al : WHO classification of tumours of the digestive system, 4th ed, International Agency for Research on Cancer, Lyon, 2010
 
2) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
3) Charbel H, Al-Kawas FH : Cholangiocarcinoma : epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep 13 : 182-187, 2011
PubMed
4) Nakeeb A, Pitt HA, Sohn TA et al : Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 : 463-473 ; discussion 473-475, 1996
 
5) Edge S, Byrd D, Compton C et al : AJCC Cancer Staging Manual, 7th ed, Springer, New York, 2010
 
6) Gore RM, Shelhamer RP : Biliary tract neoplasms : diagnosis and staging. Cancer Imaging 7 Spec No A : S15-23, 2007
 
7) Blechacz B, Komuta M, Roskams T et al : Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8 : 512-522, 2011
PubMed
8) Sobin LH, Gospodarowicz MK, Wittekind C : International Union Against Cancer (UICC) TNM classification of malignant tumours, 7th ed, Wiley-Blackwell, Oxford, 2010
 
9) Deoliveira ML, Schulick RD, Nimura Y et al : New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53 : 1363-1371, 2011
 
10) Razumilava N, Gores GJ : Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol 11 : 13-21 e1, quiz e3-4, 2013
 
11) Cha JM, Kim MH, Jang SJ : Early bile duct cancer. World J Gastroenterol 13 : 3409-3416, 2007
PubMed
12) Fischer HP, Zhou H : Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 11 : 301-309, 2004
PubMed
13) Chu PG, Schwarz RE, Lau SK et al : Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma : application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol 29 : 359-367, 2005
PubMed
14) Albores-Saavedra J, Nadji M, Henson DE : Intestinal-type adenocarcinoma of the gallbladder. A clinicopathologic study of seven cases. Am J Surg Pathol 10 : 19-25, 1986
 
15) Li L, Chen QH, Sullivan JD et al : Signet-ring cell carcinoma of the ampulla of Vater. Ann Clin Lab Sci 34 : 471-475, 2004
 
16) Avery AK, Beckstead J, Renshaw AA et al : Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24 : 203-210, 2000
PubMed
17) Hata T, Sakata N, Aoki T et al : Repeated pancreatectomy for metachronous duodenal and pancreatic metastases of renal cell carcinoma. Case Rep Gastroenterol 7 : 442-448, 2013
PubMed
18) Tong GX, Yu WM, Beaubier NT et al : Expression of PAX8 in normal and neoplastic renal tissues : an immunohistochemical study. Mod Pathol 22 : 1218-1227, 2009
PubMed
19) Miyazawa M, Torii T, Toshimitsu Y et al : Alpha-fetoprotein-producing clear cell carcinoma of the extrahepatic bile ducts. J Clin Gastroenterol 40 : 555-557, 2006
PubMed
20) Yamana I, Kawamoto S, Nagao S et al : Squamous cell carcinoma of the hilar bile duct. Case Rep Gastroenterol 5 : 463-470, 2011
PubMed
21) Kijima H, Takeshita T, Suzuki H et al : Carcinosarcoma of the ampulla of Vater : a case report with immunohistochemical and ultrastructural studies. Am J Gastroenterol 94 : 3055-3059, 1999
PubMed
22) Tanaka A, Hirabayashi K, Tobita K et al : Carcinosarcoma of the ampulla of Vater. J Clin Gastroenterol 42 : 864-865, 2008
PubMed
P.93 掲載の参考文献
1) 日本胆道外科研究会編 : 外科・病理 胆道癌取扱い規約, 第5版, 金原出版, 2003
 
2) Bosman FT, Carnerio F, Hruban RH (eds) : WHO Classification of Tumours of the Digestive System, Lyon, IRAC Press, 2003, pp13-14, pp274-276
 
3) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2014
 
4) El Rassi ZS, Mohsine RM, Berger F et al : Endocrine tumors of the extrahepatic bile ducts. Pathological and clinical aspects, surgical management and outcome. Hepatogastroenterology 59 : 1295-1300, 2004
PubMed
5) Modlin IM, Shapiro MD, Kidd M : An analysis of rare carcinoid tumors : clarifying these clinical conundrums. World J Surg 29 : 92-101, 2004
 
6) 山本健太, 磯谷正敏, 岩田洋介他 : 粘膜下腫瘍様の形態を呈した胆嚢原発内分泌癌の1例. 胆道 24 : 603-610, 2010
 
7) Nishigami T, Yamada M, Nakasho K et al : Carcinoid tumor of the gall bladder. Intern med 35 : 953-956, 1996
PubMed
8) Nafidi O, Nguyen BN, Roy A : Carcinoid tumor of the common bile duct : a rare complication of von Hippel-Lindau syndrome. World J gastroenterol 14 : 1299-1301, 2008
PubMed
9) Volante M, Brizzi MP, Faggiano A et al : Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors : a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20 : 1172-1182, 2007
PubMed
10) 岩淵三哉, 佐野壽昭 : 消化管 (肝・胆管を含む) の内分泌腫瘍. 病理と臨床 17 : 1253-1262, 1999
 
11) Harada K, Sato Y, Ikeda H et al : Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Virchows Arch 460 : 281-289, 2012
PubMed
12) Albores-Saavedra J et al : Tumors of the Gallbladder, Extrahepatic bile ducts, and Ampulla of vater. Atlas of the tumor pathology, 3rd series fascicle 27, Armed Forces Institute of Pathology, Washington DC, 1998
 
13) Sarma DP, Rodriguez FH Jr, Hoffmann EO : Paraganglioma of the hepatic duct. South Med J 73 : 1677-1678, 1980
PubMed
14) Okubo Y, Wakayama M, Nemoto T et al : Literature survey on epidemiology and pathology of gangliocytic paraganglioma. BMC cancer 11 : 187, 2011
PubMed
15) Perrone T, Sibley RK, Rosai J : Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol 9 : 31-41, 1985
 
P.99 掲載の参考文献
1) Murakata LA, Ishak KG : Expression of inhibin-alpha by granular cell tumors of the gallbladder and extrahepatic bile ducts. Am J Surg Pathol 25 : 1200-1203, 2001
PubMed
2) Fenoglio L, Severini S, Cena P et al : Common bile duct schwannoma : a case repor t and review of literature. World J Gastroenterol 13 : 1275-1278, 2007
 
3) Ray S, Das K, Mridha AR et al : Neurofibroma of the common bile duct : a rare cause of obstructive jaundice. Am J Surg 202 : e1-3, 2011
PubMed
4) Sakorafas GH, Giannopoulos GA, Parasi A et al : Large somatostatin-producing endocrine carcinoma of the ampulla of vater in association with GIST in a patient with von Recklinghausen's disease, Case report and review of the literature. JOP 9 : 633-639, 2008
 
5) Wachter DL, Buttner MJ, Grimm K et al : Leiomyoma of the gallbladder : a case report with review of the literature and discussion of the differential diagnosis. J Clin Pathol 63 : 177-179, 2010
PubMed
6) Sumiyoshi T, Shima Y, Okabayashi T et al : Heterotopic pancreas in the common bile duct, with a review of the literature. Intern Med 53 : 2679-2682, 2014
PubMed
7) Fukuda S, Mukai S, Shimizu S et al : Heterotopic gastric mucosa in the hilar bile duct mimicking hilar cholangiocarcinoma : report of a case. Surg Today 43 : 91-95, 2013
PubMed
8) Nemade B, Talapatra K, Shet T et al : Embryonal rhabdomyosarcoma of the biliary tree mimicking a choledochal cyst. J Cancer Res Ther 3 : 40-42, 2007
PubMed
9) Al-Daraji WI, Makhlouf HR, Miettinen M et al : Primary gallbladder sarcoma : a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma. Am J Surg Pathol 33 : 826-834, 2009
PubMed
10) Park EY, Seo HI, Yun SP et al : Primary leiomyosarcoma of gallbladder. J Korean Surg Soc 83 : 403-407, 2012
PubMed
11) 二上文夫, 小西孝司, 山本精一 他 : 総胆管平滑筋肉腫の1例. 胆道 8 : 458-462, 1994
Medical*Online
12) Filippou DK, Pashalidis N, Skandalakis P et al : Malignant gastrointestinal stromal tumor of the ampulla of Vater presenting with obstructive jaundice. J Postgrad Med 52 : 204-206, 2006
PubMed
13) Park JK, Choi SH, Lee S et al : Malignant gastrointestinal stromal tumor of the gallbladder. J Korean Med Sci 19 : 763-767, 2004 (Review)
 
14) Martin Malagon A, Lopez-Tomassetti Fernandez E, Arteaga Gonzalez I et al : Inflammatory myofibroblastic tumor of the distal bile duct associated with lymphoplasmacytic sclerosing pancreatitis. Case report and review of the literature. Pancreatology 6 : 145-154, 2006
PubMed
P.105 掲載の参考文献
1) Zen Y, Harada K, Sasaki M et al : IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis : do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28 : 1193-1203, 2004
PubMed
2) Zen Y, Quaglia A, Heaton N et al : Two distinct pathways of carcinogenesis in primary sclerosing cholangitis. Histopathology 59 : 1100-1110, 2011
PubMed
3) Zen Y, Quaglia A, Portmann B : Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology 58 : 414-422, 2011
PubMed
4) Portmann B, Zen Y : Inflammatory disease of the bile ducts-cholangiopathies : liver biopsy challenge and clinicopathological correlation. Histopathology 60 : 236-248, 2012
PubMed
5) Zen Y, Nakanuma Y, Portmann B : Immunoglobulin G4-related sclerosing cholangitis : pathologic features and histologic mimics. Semin Diagn Pathol 29 : 205-211, 2012
PubMed
6) Oseini AM, Chaiteerakij R, Shire AM et al : Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 54 : 940-948, 2011
PubMed
7) Boonstra K, Culver EL, de Buy Wenniger LM et al : Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59 : 1954-1963, 2014
PubMed
8) Umemura T, Zen Y, Hamano H et al : Immunoglobin G4-hepatopathy : association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46 : 463-471, 2007
PubMed
9) Zen Y, Fujii T, Sato Y et al : Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 20 : 884-894, 2007
PubMed
10) Zen Y, Ishikawa A, Ogiso S et al : Follicular cholangitis and pancreatitis-clinicopathological features and differential diagnosis of an under-recognized entity. Histopathology 60 : 261-269, 2012
PubMed
P.115 掲載の参考文献
1) 福井次矢, 黒川清監 : ハリソン内科学, 第3版, メディカルサイエンスインターナショナル, 2009, pp2058-2063
 
2) 鬼島宏 : 胆嚢・胆管, 向井清, 真鍋俊明, 深山正久編 : 外科病理学, 第4版, 文光堂, 2006, pp665-698
 
3) Duarte I, Llanos O, Domke H et al : Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer 72 : 1878-1884, 1993
PubMed
4) 鬼島宏 : 胆嚢癌の壁内浸潤様式. 胆道 22 : 207-216, 2008
Medical*Online
5) 急性胆管炎・胆嚢炎診療ガイドライン改訂出版委員会編 : -TG13新基準掲載-急性胆管炎・胆嚢炎診療ガイドライン 2013, 医学図書出版, 2013
 
6) 糸井隆夫, 渡辺英伸, 武井和夫他 : 急性胆嚢炎の病理-肉眼型の分類・移行と急性胆嚢炎合併胆嚢癌との鑑別-. 腹部画像診断 14 : 143-156, 1994
 
7) 広岡保明, 中泉明彦, 岡輝明他 : 胆汁細胞診の採取・判定方法に関する研究 (第1報) -貯留胆汁細胞診の細胞判定基準-. 日臨細胞会誌 49 : 7-14, 2010
 
8) Stephen AE, Berger DL : Carcinoma in the porcelain gallbladder : a relationship revisited. Surgery 129 : 699-703, 2001
PubMed
9) Shimizu M, Miura J, Tanaka T et al : Porcelain gallbladder : relation between its type by ultrasound and incidence of cancer. J Clin Gastroenterol 11 : 471-476, 1989
 
10) 北川晋, 中川正昭, 山田哲司他 : 黄色肉芽腫性胆嚢炎の臨床病理学的検討. 日外会誌 91 : 1001-1010, 1990
 
11) Abraham SC, Cruz-Correa M, Argani P et al : Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol 27 : 441-451, 2003
PubMed
12) 河野博, 中村雅史, 永吉洋介他 : 腹腔鏡下胆嚢摘出術におけるIncidental gallbladder cancerの頻度. 胆と膵 32 : 373-377, 2011
Medical*Online
P.123 掲載の参考文献
1) 日本膵臓学会編 : 臨床・病理 膵癌取扱い規約, 第6版補訂版, 金原出版, 2013
 
2) Terris B, Fukushima N, Hruban RH et al : Serous neoplasms of the pancreas. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO Classification of Tumours of the Digestive System", 4th ed, IARC, Lyon, 2010, pp296-299
 
3) Sedivy R, Patzak B : Pancreatic diseases past and present : a historical examination of exhibition specimens from the Collectio Rokitansky in Vienna. Virchows Arch 441 : 12-18, 2002
PubMed
4) Compagno J, Oertel JE : Microcystic adenomas of the pancreas (glycogen-rich cystadenomas) : a clinicopathologic study of 34 cases. Am J Clin Pathol 69 : 289-298, 1978
PubMed
5) Hodgkinson DJ, ReMine WH, Weiland LH : Pancreatic cystadenoma. A clinicopathologic study of 45 cases. Arch Surg 113 : 512-519, 1978
PubMed
6) Kimura W, Moriya T, Hirai I et al : Multicenter study of serous cystic neoplasm of the Japan pancreas society. Pancreas 41 : 380-387, 2012
PubMed
7) Tseng J, Warshaw A, Sahani DV et al : Serous Cystadenoma of the pancreas : tumor growth rates and recommendations for treatment. Ann Surg 242 : 413-421, 2005
PubMed
8) Le Borgne J, de Calan L, Partensky C et al : Cystadenomas and cystadenocarcinomas of the pancreas : a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 230 : 152-156, 1999
PubMed
9) Bassi C, Salvia R, Molinari E et al : Management of 100 consecutive cases of pancreatic serous cystadenoma : wait for symptoms and see at imaging or vice versa? World J Surg 27 : 319-323, 2003
PubMed
10) Galanis C, Zamani A, Cameron JL et al : Resected serous cystic neoplasms of the pancreas : a review of 158 patients with recommendations for treatment. J Gastrointest Surg 11 : 820-826, 2007
PubMed
11) 一二三倫郎, 西東龍一, 竹熊与志 他 : CT, MRI所見からみたSCT-良, 悪性の鑑別は可能か. 胆と膵 24 : 245-253, 2003
Medical*Online
12) Kanno A, Satoh K, Hamada S et al : Serous cystic neoplasms of the whole pancreas in a patient with von Hippel-Lindau disease. Intern Med 50 : 1293-1298, 2011
 
13) 岡田恒良, 野浪敏明, 三輪高也 他 : 原発巣摘除4年後に肝転移巣摘除を行った膵漿液性嚢胞腺癌の1例. 日消誌 88 : 2719-2723, 1991
 
14) Philips CA, Kalal CR, Bihari C et al : Unique presentation of giant metastatic microcystic serous adenocarcinoma of the pancreas. Case Rep Gastrointest Med 2014 : 913745, 5pages, 2014
 
15) Bramis K, Petrou A, Papalambros A et al : Serous cystadenocarcinoma of the pancreas : report of a case and management reflections. World J Surg Oncol 10 : 51, 2012
PubMed
16) Zirinsky K, Abiri M, Baer JW : Computed tomography demonstration of pancreatic microcystic adenoma. Am J Gastroenterol 79 : 139-142, 1984
PubMed
17) George DH, Murphy F, Michalski R et al : Serous cystadenocarcinoma of the pancreas : a new entity? Am J Surg Pathol 13 : 61-66, 1989
PubMed
18) 箱崎幸也, 白浜竜興, 大庭健一他 : 肝膿瘍が発見契機となった膵・肝漿液性嚢胞腺腫の1例. 胆と膵 12 : 1017-1024, 1991
 
19) Yoshimi N, Sugie S, Tanaka T et al : A rare case of serous cystadenocarcinoma of the pancreas. Cancer 69 : 2449-2453, 1992
 
20) Eriguchi N, Aoyagi S, Nakayama T et al : Serous cystadenocarcinoma of the pancreas with liver metastases. J Hepatobiliary Pancreat Surg 5 : 467-470, 1998
PubMed
21) Strobel O, Z'graggen K, Schmitz-Winnenthal FH et al : Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion. 68 : 24-33, 2003
PubMed
22) Franko J, Cole K, Pezzi CM et al : Serous cystadenocarcinoma of the pancreas with metachronous hepatic metastasis. Am J Clin Oncol 31 : 624-625, 2008
PubMed
23) Widmaier U, Mattfeldt T, Siech M et al : Serous cystadenocarcinoma of the pancreas. Int J Pancreatol 20 : 135-139, 1996
PubMed
24) 梅津哉, 内藤眞, 木村格平 : 膵臓に発生した漿液性嚢胞腺癌の1例 : 新潟医学会雑誌 110 : 72-77, 1996
Medical*Online
25) Matsumoto T, Hirano S, Yada K et al : Malignant serous cystic neoplasm of the pancreas. J Clin Gastroenterol 39 : 253-256, 2005
PubMed
26) 湯浅吉夫, 角重信, 中光篤志 : 浸潤性増殖およびリンパ節転移を伴っていた漿液性嚢胞腺癌の1例. 日消外会誌 42 : 1419-1423, 2009
 
27) Wasel BA, Keough V, Huang WY et al : Histological percutaneous diagnosis of stage IV microcystic serous cystadenocarcinoma of the pancreas. BMJ Case Rep. 2013 Jan 30 ; 2013. pii : bcr2012007924. doi : 10.1136/bcr-2012-007924
 
28) Kosmahl M, Wagner J, Peters K et al : Serous cystic neoplasms of the pancreas : an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol 28 : 339-346, 2004
PubMed
29) Liszka L, Pajak J, Golka D : Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas. Pathol Res Pract 210 : 901-908, 2014
 
30) Thirabanjasak D, Basturk O, Altinel D et al : Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis? Pancreatology 9 : 182-188, 2009
 
P.129 掲載の参考文献
1) Compagno J, Oertel JE : Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol 69 : 573-580, 1978
PubMed
2) Ohashi K, Murakami Y, Maruyama M et al : Four cases of mucin-secreting pancreatic cancer. Prog Dig Endosc 20 : 348-351, 1982
 
3) 加藤洋, 柳沢昭夫 : 粘液産生膵癌-概念と分類. 胆と膵 7 : 731-737, 1986
 
4) Hruban RH, Pitman MB, Klimstra : AFIP Atlas of Tumor Pathology, Tumors of the pancreas. Fouth Series, Fascicle 6, Armed Forces Institute of Pathology, Washington DC, 2007, pp51-74
 
5) Zamboni G, Fukushima N, RH Hruban et al : Mucinous cystic neoplasms of the pancreas. in T Bosman, Fatima Carneiro, RH Hruban, Neil D (eds) : "World Health Organization Classification of Tumours of Digestive system", IARC Press, Lyon, 2010, pp300-303
 
6) 日本膵臓学会編 : 膵癌取扱い規約, 第6版, 金原出版, 2009
 
7) Yamao K, Yanagisawa A, Takahashi K et al : Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma. A multi-institutional study of the Japan pancreas society. Pancreas 40 : 67-71, 2011
PubMed
8) 須田耕一, 茂垣雅俊, 松本由朗 : 膵真性嚢胞の病理診断・分類の問題点. 病理の立場から. 胆と膵 11 : 9-15, 1990
 
9) Zamboni G, Kloppel G, Hruban RH et al : Mucinous cystic neoplasms of the pancreas. in Hamilton SR, Aaltonen LA (eds) : "World Health Organization Classification of Tumors, Pathology and genetics of tumours of the digestive system", IARC Press, Lyon, 2000, pp234-236
 
10) Shiono S, Suda K, Nobukawa B et al : Pancreatic, hepatic, splenic and mesenteric mucinous cystic neoplasms (MCNs) are lumped together as extraovarian MCN. Pathol Int 56 : 71-77, 2006
 
11) Zamboni G, Scarpa A, Bogina G et al : Mucinous cystic tumor of the pancreas : Clinicopathological features, prognosis and relationship to other mucinous cystic tumors. Am J Surg Pathol 23 : 410-422, 1999
PubMed
12) Suda K, Takase M, Oyama T et al : An osteoclast-like giant cell tumor pattern in a mucinous cystadenocarcinoma of the pancreas with lymph node metastasis in a patient surviving over 10 years. Virchows Arch 438 : 519-520, 2001
 
13) Westra WH, Styrm PJ, Drillenburg P et al : K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver : Genetic evidence to support origin from the duct epithelium. Am J Surg Pathol 22 : 1247-1254, 1998
 
14) van den Berg W, Tascilar M, Offerhaus GJ et al : Pancreatic mucinous cystic neoplasms with sarcomatous stroma. Molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous component. Mod Pathol 13 : 86-91, 2000
PubMed
15) Wenig BM, Albores-Saavdra J, Buetow PC et al : Pancreatic mucinous cystic neoplasm with sarcomatous stroma : A report of three cases. Am J Surg Pathol 21 : 70-80, 1997
 
16) Silverman JF, Zhu B, Liu Y et al : Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung. Histol Histopathol 24 : 77-82, 2009
PubMed
17) Luttges J, Feyerabend B, Buchelt T et al : The mucin profile of noninvasive and invasive mucinous cystic neoplasm of the pancreas. Am J Surg Pathol 26 : 466-471, 2002
 
18) Tanaka M, Shibahara J, Fukushima N et al : Claudin-18 is an early-stage marker of pancreatic carcinogenesis. J Histochem Cytochem 59 : 942-952, 2011
PubMed
19) Tanaka M, Chari S, Adsay V : International consensus Guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6 : 17-32, 2006
PubMed
P.136 掲載の参考文献
1) Adsay NV, Fukushima N, Furukawa T et al : Intraductal neoplasms of the pancreas. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO Classification of Tumours of the Digestive System", International Agency for Research on Cancer, Lyon, 2010, pp304-313
 
2) 日本膵臓学会編 : 膵癌取扱い規約, 第6版, 金原出版, 2009
 
3) Furukawa T, Hatori T, Fujita I et al : Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 60 : 509-516, 2011
PubMed
4) Tanaka M, Fernandez-del Castillo C, Adsay V et al : International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12 : 183-197, 2012
PubMed
5) Yamaguchi K, Kanemitsu S, Hatori T et al : Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 40 : 571-580, 2011
PubMed
6) Yamaguchi H, Shimizu M, Ban S et al : Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 33 : 1164-1172, 2009
PubMed
7) Motosugi U, Yamaguchi H, Furukawa T et al : Imaging studies of intraductal tubulopapillary neoplasms of the pancreas : 2-tone duct sign and cork-of-wine-bottle sign as indicators of intraductal tumor growth. J Comput Assist Tomogr 36 : 710-717, 2012
PubMed
8) Furukawa T, Kloppel G, Volkan Adsay N et al : Classification of types of intraductal papillary-mucinous neoplasm of the pancreas : a consensus study. Virchows Arch 447 : 794-799, 2005
PubMed
9) Yamaguchi H, Inoue T, Eguchi T et al : Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 20 : 552-561, 2007
PubMed
10) Ban S, Naitoh Y, Mino-Kenudson M et al : Intraductal papillary mucinous neoplasm (IPMN) of the pancreas : its histopathologic difference between 2 major types. Am J Surg Pathol 30 : 1561-1569, 2006
PubMed
11) Adsay NV, Merati K, Basturk O et al : Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms : delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 28 : 839-848, 2004
PubMed
12) Tajiri T, Inagaki T, Ohike N et al : Intraductal oncocytic papillary carcinoma of the pancreas showing numerous hyaline globules in the lumen. Pathol Int 60 : 48-54, 2010
PubMed
13) 山口浩, 永田耕治, 清水道生 : 膵粘液産生性腫瘍の病理診断. 病理と臨床 27 : 539-545, 2009
Medical*Online
14) Ban D, Shimada K, Sekine S et al : Pancreatic ducts as an important route of tumor extension for acinar cell carcinoma of the pancreas. Am J Surg Pathol 34 : 1025-1036, 2010
PubMed
15) Basturk O, Zamboni G, Klimstra DS et al : Intraductal and papillary variants of acinar cell carcinomas : a new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol 31 : 363-370, 2007
 
16) Furukawa T, Kuboki Y, Tanji E et al : Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1 : 161, 2011
PubMed
17) Wu J, Matthaei H, Maitra A et al : Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 3 : 92ra66, 2011
PubMed
18) Kanda M, Matthaei H, Wu J et al : Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 142 : 730-733 e9, 2012
 
19) Yamaguchi H, Kuboki Y, Hatori T et al : Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Surg Pathol 35 : 1812-1817, 2011
PubMed
P.148 掲載の参考文献
1) Kilimstra D, Kloppel G : Tumors of the exocrine pancreas. in Fletcher C (ed) : "Diagnostic Histopathology of Tumors", 4th ed, Saunders, Philadelphia, 2013, pp 531-588
 
2) Bosman FT, Carneiro F, Hruban RH et al : WHO Classification of Tumours of the Digestive System, IARC, Lyon, 2010, pp279-337
 
3) Hruban RH, Pitman MB, Klimstra DS : Tumors of the Pancreas. AFIP Atlas of Tumor Pathology, Vol. 6, 4th ed, ARP Press, Washington, 2007, pp 111-164
 
4) Hruban RH, Takaori K, Klimstra DS et al : An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28 : 977-987, 2004
PubMed
5) Yamaguchi K, Kanemitsu S, Hatori T et al : Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 40 : 571-580, 2011
PubMed
6) Luttges J, Schemm S, Vogel I et al : The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol 191 : 154-161, 2000
 
7) Adsay V, Logani S, Sarkar F et al : Foamy gland pattern of pancreatic ductal adenocarcinoma : a deceptively benignappearing variant. Am J Surg Pathol 24 : 493-504, 2000
PubMed
8) Bagci P, Andea AA, Basturk O et al : Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns : a potential microscopic mimic of noninvasive ductal neoplasia. Mod Pathol 25 : 439-448, 2012
PubMed
9) Dursun N, Feng J, Basturk O et al : Vacuolated cell pattern of pancreatobiliary adenocarcinoma : a clinicopathological analysis of 24 cases of a poorly recognized distinctive morphologic variant important in the differential diagnosis. Virchows Arch 457 : 643-649, 2010
PubMed
10) Luttges J, Vogel I, Menke M et al : Clear cell carcinoma of the pancreas : an adenocarcinoma with ductal phenotype. Histopathology 32 : 444-448, 1998
PubMed
11) Reid MD, Basturk O, Thirabanjasak D et al : Tumor-infiltrating neutrophils in pancreatic neoplasia. Mod Pathol 24 : 1612-1619, 2011
 
12) Jones S, Zhang X, Parsons DW et al : Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321 : 1801-1806, 2008
PubMed
13) Wilentz RE, Su GH, Dai JL et al : Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Am J Pathol 156 : 37-43, 2000
PubMed
14) Bandyopadhyay S, Basturk O, Coban I et al : Isolated solitary ducts (naked ducts) in adipose tissue : a specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate. Am J Surg Pathol 33 : 425-429, 2009
PubMed
15) Sharma S, Green KB : The pancreatic duct and its arteriovenous relationship : an underutilized aid in the diagnosis and distinction of pancreatic adenocarcinoma from pancreatic intraepithelial neoplasia. A study of 126 pancreatectomy specimens. Am J Surg Pathol 28 : 613-620, 2004
PubMed
16) Bartow SA, Mukai K, Rosai J : Pseudoneoplastic proliferation of endocrine cells in pancreatic fibrosis. Cancer 47 : 2627-2633, 1981
PubMed
17) Voong KR, Davison J, Pawlik TM et al : Resected pancreatic adenosquamous carcinoma : clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol 41 : 113-122, 2010
PubMed
18) Adsay NV, Pierson C, Sarkar F et al : Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 25 : 26-42, 2001
PubMed
19) Poultsides GA, Reddy S, Cameron JL et al : Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 251 : 470-476, 2010
PubMed
20) Wilentz RE, Goggins M, Redston M et al : Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas : A newly described and characterized entity. Am J Pathol 156 : 1641-1651, 2000
PubMed
21) Banville N, Geraghty R, Fox E et al : Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Hum Pathol 37 : 1498-1502, 2006
 
22) Paner GP, Thompson KS, Reyes CV : Hepatoid carcinoma of the pancreas. Cancer 88 : 1582-1589, 2000
PubMed
23) Chow LT, Chow WH : Signet-ring mucinous adenocarcinoma of the pancreas. Chin Med Sci J 9 : 176-178, 1994
PubMed
24) Paal E, Thompson LD, Frommelt RA et al : A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. Ann Diagn Pathol 5 : 129-140, 2001
PubMed
25) Conlon KC, Klimstra DS, Brennan MF : Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223 : 273-279, 1996
PubMed
26) Ueno H, Ioka T, Ikeda M et al : Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan : GEST study. J Clin Oncol 31 : 1640-1648, 2013
PubMed
P.153 掲載の参考文献
1) Cruickshank AH : Pathology of the pancreas, Springer, 1995
 
2) Wisnoski NC, Townsend CM, Jr. Nealon WH et al : 672 patients with acinar cell carcinoma of the pancreas : a population-based comparison to pancreatic adenocarcinoma. Surgery 144 : 141-148, 2008
PubMed
3) Schmidt CM, Matos JM, Bentrem DJ et al : Acinar cell carcinoma of the pancreas in the United States : prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg 12 : 2078-2086, 2008
PubMed
4) Ang C, Herran LA, Lagunes DR et al : A case report of a patient with advanced acinar cell carcinoma of the pancreas : long-term survival with regional, systemic and targeted therapy. Tumori 99 : e61-64, 2013
PubMed
5) Schempf U, Sipos B, Konig C et al : FOLFIRINOX as firstline treatment for unresectable acinar cell carcinoma of the pancreas : a case report. Z Gastroenterol 52 : 200-203, 2014
PubMed
6) Ban D, Shimada K, Sekine S et al : Pancreatic ducts as an important route of tumor extension for acinar cell carcinoma of the pancreas. Am J Surg Pathol 34 : 1025-1036, 2010
PubMed
7) La Rosa S, Adsay V, Alberello L et al : Clinicopathologic study of 62 Acinar cell carcinomas of the pancreas. Am J Surg Pathol 36 : 1782-1795, 2012
 
8) Ordonez NG : Pancreatic acinar cell carcinoma. Adv Anat Pathol 8 : 144-159, 2001
PubMed
9) La Rosa S, Franzi F, Marchet S et al : The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch 454 : 133-142, 2009
PubMed
10) Tajiri T, Tate G, Inagaki T et al : Intraductal tubular neoplasms of the pancreas : histogenesis and differentiation. Pancreas 30 : 115-121, 2005
PubMed
11) Yamaguchi H, Shimizu M, Ban S et al : Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 33 : 1164-1172, 2009
PubMed
12) El-Bahrawy MA, Rowan A, Horncastle D et al : Stamp, G. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas. Am J Surg Pathol 32 : 1-7, 2008
 
13) Abraham SC, Wu TT, Hruban RH et al : Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma : frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 160 : 953-962, 2002
PubMed
14) Moore PS, Orlandini S, Zamboni G et al : Pancreatic tumours : molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 84 : 253-262, 2001
PubMed
15) Terhune PG, Memoli VA, Longnecker DS : Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice. Pancreas 16 : 6-12, 1998
PubMed
16) Hoorens A, Lemoine NR, McLellan E et al : Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 143 : 685-698, 1993
PubMed
P.161 掲載の参考文献
1) Bosman F, Camerio F, Hruban R et al : WHO classification of tumours of the digestive system, IARC Press, Lyon, 2010
 
2) Ito T, Sasano H, Tanaka M et al : Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 45 : 234-243, 2010
PubMed
3) Ito T, Igarashi H, Nakamura K et al : Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan : a nationwide survey analysis. J Gastroenterol 2014 Feb 6. [Epub ahead of print]
 
4) Yao JC, Hassan M, Phan A et al : One hundred years after "carcinoid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26 : 3063-3072, 2010
 
5) Bordeianou L, Vagefi PA, Sahani D et al : Cystic pancreatic endocrine neoplasms : a distinct tumor type? J Am Coll Surg 206 : 1154-1158, 2008
PubMed
6) Velayoudom-Cephise FL, Duvillard P, Foucan L et al : Are G3 ENETS neuroendocrine neoplasms heterogeneous? Endocr Relat Cancer 20 : 649-657, 2013
 
7) Ohike N, Kosmahl M, Kloppel G : Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchoes Arch 445 : 231-235, 2004
PubMed
8) Volante M, La Rosa S, Castellano I et al : Clinico-pathological features of a series of 11 oncocytic endocrine tumours of the pancreas. Virchows Arch 448 : 545-551, 2008
 
9) Kim MJ, Jang SJ, Yu E : Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas. Hum Pathol 39 : 251-258, 2008
PubMed
10) Singhi AD, Lilo M, Hruban RH et al : Overexpression of Lymphoid Enhancer-Binding Factor 1 (LEF1) in solidpseudopapillary neoplasms of the pancreas. Mod Pathol 27 : 1355-1363, 2014
PubMed
11) Kanehira K, Khoury T : Neuroendocrine markers expression in pancreatic serous cystadenoma. Appl Immunohistochem Mol Morphol 19 : 141-146, 2011
 
12) Kosmahl M, Wagner J, Peters K et al : Serous cystic neoplasms of the pancreas : an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol 28 : 339-346, 2004
PubMed
13) Hosoda W, Sasaki E, Murakami Y et al : BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens. Pathol Int 63 : 176-182, 2013
PubMed
14) Hammel PR, Vilgrain V, Terris B et al : Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterol 119 : 1087-1095, 2013
 
15) Jiao Y, Shi C, Edil BH et al : DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331 : 1199-1203, 2011
PubMed
16) Volante M, Brizzi MP, Faggiano A et al : Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors : a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20 : 1172-1182, 2007
PubMed
17) Kasajima A, Yazdani S, Sasano H : Pathology diagnosis of pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci. 2015 Feb 2. doi : 10.1002/jhbp.208. [Epub ahead of print]
 
P.167 掲載の参考文献
1) Kloppel G, Hruban R, Klimstra D et al : Solid-pseudopapillary neoplasm of the pancreas. in Bosman F, Carneiro F, Hruban R et al (eds) : "WHO Classification of the Digestive System", World Health Organization Classification of the Tumors, IARC Press, Lyon, 2010, pp327-330
 
2) Buetow PC, Buck JL, Pantongrag-Brown L et al : Solid and papillary epithelial neoplasm of the pancreas : imagingpathologic correlation on 56 cases. Radiology 199 : 707-711, 1996
PubMed
3) Nishihara K, Nagoshi M, Tsuneyoshi M et al : Papillary cystic tumors of the pancreas. Assessment of their malignant potential. Cancer 71 : 82-92, 1993
PubMed
4) Albores-Saavedra J, Simpson KW, Bilello SJ : The clear cell variant of solid pseudopapillary tumor of the pancreas : a previously unrecognized pancreatic neoplasm. Am J Surg Pathol 30 : 1237-1242, 2006
PubMed
5) Tanaka Y, Kato K, Notohara K et al : Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 61 : 8401-8404, 2001
PubMed
6) Abraham SC, Klimstra DS, Wilentz RE et al : Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 160 : 1361-1369, 2002
PubMed
7) 稲川朋子, 荒川昭子, 国村利明 他 : 膵solid cystic tumor 4例の細胞像. 日臨細胞会誌 40 : 378-382, 2001
 
P.178 掲載の参考文献
1) 大池信之 : 非膵管上皮系腫瘍の鑑別診断. 病理と臨床 31 : 285-296, 2013
Medical*Online
2) Fletcher CDM, Bridge JA, Hogendoorn PCW et al : WHO Classification of Tumours of Soft Tissue & Bone, 4th ed, 2013
 
3) Miettnen M, Fetsch JF, Antonescu CR et al : AFIP Atlas of Tumor Pathology, 4th Series, Fascicle 20-Tumors of the Soft Tissues, 2014
 
4) 長谷川匡, 小田義直編 : 腫瘍病理鑑別診断アトラス 軟部腫瘍, 文光堂, 2011
 
5) 大池信之, 磯崎正典, 杉山朋子 他 : Groove pancreatitisの病理像. 胆と膵 34 : 271-277, 2013
Medical*Online
6) 佐野壽昭, 大池信之 : 各論 第9章 内分泌器, F. 膵島, 笠原正典, 石倉浩, 佐藤昇志編 : 器官病理学, 第14版, 南山堂, 2013, pp614-615
 
7) Cao W, Adley BP, Liao J et al : Mucinous nonneoplastic cyst of the pancreas : apomucin phenotype distinguishes this entity from intraductal papillary mucinous neoplasm. Hum Pathol 41 : 513-521, 2010
PubMed
8) Adsay NV, Zamboni G : Paraduodenal pancreatitis : a clinicopathologically distinct entity unifying "cystic dystrophy of heterotopic pancreas", "para-duodenal wall cyst", and "groove pancreatitis". Semin Diagn Pathol 21 : 247-254, 2004
PubMed
9) Klimstra DS, Hruban RH, Kloppel G et al : Acinar cell neoplasms of the pancreas. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO Classification of Tumours of the Digestive System", 4th ed, International Agency for Research on Cancer, Lyon, 2010, pp314-318
 
P.187 掲載の参考文献
1) Hruban RH, Pitman MB, Klimstra DS : Tumors of the Pancreas. Afip Atlas of Tumor Pathology (4th Series Fascicle 6), American Registry of Pathology, Washington, 2004, pp325-334
 
2) Campbell F, Verbeke CS : Pathology of the Pancreas : A Practical Approach, Springer, 2013, pp171-176
 
3) Adsay NV, Andea A, Basturk O et al : Secondary tumours of the pancreas : An analysis of a surgical and autopsy database and review of the literature. Virchows Arch 444 : 527-535, 2004
 
4) Hiotis SP, Klimstra DS, Conlon KC et al : Results after pancreatic resection for metastatic lesions. Ann Surg Oncol 9 : 675-679, 2002
PubMed
5) Reddy S1, Wolfgang CL : The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol 10 : 287-293, 2009
 
6) Crippa S, Angelini C, Mussi C et al : Surgical treatment of metastatic tumors to the pancreas : a single center experience and review of the literature. World J Surg 30 : 1536-1542, 2006
 
7) Adler H, Redmond CE, Heneghan HM et al : Pancreatectomy for metastatic disease : a systematic review. Eur J Surg Oncol 40 : 379-386, 2014
PubMed
8) Sperti C, Moletta L, Patane G : Metastatic tumors to the pancreas : The role of surgery. World J Gastrointest Oncol 6 : 381-392, 2014
 
9) Nakamura E, Shimizu M, Itoh T et al : Secondary tumors of the pancreas : clinicopathological study of 103 autopsy cases of Japanese patients 51 : 686-690, 2001
PubMed
10) Wente MN, Kleeff J, Esposito I et al : Renal cancer cell metastasis into the pancreas : a single-center experience and overview of the literature. Pancreas 30 : 218-222, 2005
PubMed
11) Thompson LD, Heffess CS : Renal cell carcinoma to the pancreas in surgical pathology material. Cancer 89 : 1076-1088, 2000
 
12) Matsukuma S, Suda K, Abe H : Metastatic cancer involving pancreatic duct epithelium and its mimicry of primary pancreatic cancer. Histopathology 30 : 208-213, 1997
PubMed
13) Waters L, Si Q, Caraway N et al : Secondary tumors of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration : a 10-year experience. Diagn Cytopathol 42 : 738-743, 2014
PubMed
14) Olson MT, Wakely PE Jr, Ali SZ : Metastases to the pancreas diagnosed by fine-needle aspiration. Acta Cytol 57 : 473-480, 2013
 
15) Bennington JL : Proceedings : Cancer of the kidney--etiology, epidemiology, and pathology. Cancer 32 : 1017-1029, 1973
PubMed
16) Gnemmi V, Leroy X, Triboulet JP et al : Pancreatic metastases of renal clear cell carcinoma : a clinicopathological study of 11 cases with special emphasis on the usefulness of PAX2 and mesothelin for the distinction from primary ductal adenocarcinoma of the pancreas. Anal Quant Cytopathol Histpathol 35 : 157-162, 2013
PubMed
17) Gilani SM, Tashjian R, Danforth R et al : Metastatic renal cell carcinoma to the pancreas : diagnostic significance of fine-needle aspiration cytology. Acta Cytol 57 : 418-422, 2013
 
P.193 掲載の参考文献
1) Yoshida K, Toki F, Takeuchi T et al : Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40 : 1561-1568, 1995
PubMed
2) Hamano H, Kawa S, Horiuchi A et al : High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344 : 732-738, 2001
PubMed
3) Kawaguchi K, Koike M, Tsuruta K et al : Lymphoplasmacytic sclerosing pancreatitis with cholangitis : a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 22 : 387-395, 1991
PubMed
4) Notohara K, Burgart LJ, Yadav D et al : Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration : clinicopathologic features of 35 cases. Am J Surg Pathol 27 : 1119-1127, 2003
PubMed
5) Zamboni G, Luttges J, Capelli P et al : Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis : a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445 : 552-563, 2004
 
6) 日本膵臓学会・厚生労働省難治性膵疾患に関する調査研究班 : 自己免疫性膵炎臨床診断基準 2011. 膵臓 27 : 17-25, 2012
Medical*Online
7) Shimosegawa T, Chari ST, Frulloni L et al : International consensus diagnostic criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology. Pancreas 40 : 352-358, 2011
PubMed
8) Miyabe K, Notohara K, Nakazawa T et al : Histological evaluation of obliterative phlebitis for the diagnosis of autoimmune pancreatitis. J Gastroenterol 49 : 715-726, 2014
PubMed
9) Witkiewicz AK, Kennedy EP, Kennyon L et al : Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma : case report and review of the literature. Hum Pathol 39 : 1548-1551, 2008
PubMed
10) Zen Y, Fujii T, Harada K et al : Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45 : 1538-1546, 2007
PubMed
11) Guarneri F, Guarneri C, Benvenga S : Helicobacter pylori and autoimmune pancreatitis : role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 9 : 741-744, 2005
PubMed
12) Frulloni L, Lunardi C, Simone R et al : Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361 : 2135-2142, 2009
PubMed

第3部 鑑別ポイント

P.204 掲載の参考文献
1) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
2) Adsay NV, Bagci P, Tajiri T et al : Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers : pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol 29 : 127-141, 2012
PubMed
3) 日本膵臓学会編 : 膵癌取扱い規約, 第6版補訂版, 金原出版, 2013
 
4) 和田祥之, 黒田慧, 森岡恭彦 他 : 膵癌と膵内胆管癌の病理組織学的鑑別. 外科治療 49 : 230-238, 1983
 
5) 大池信之, 扇谷芳光, 青木武士 他 : 悪性胆道狭窄の病理像. 臨牀消化器内科 29 : 1189-1200, 2014
 
6) 和田祥之, 黒田慧, 森岡恭彦 他 : 下部 (膵内) 胆管癌の病理. 外科治療 49 : 725-729, 1983
 
7) Yoshida N, Esaki M, Kishi Y et al : Bile duct carcinoma involving the common channel associated with pancreaticobiliary maljunction shows an extension pattern similar to ductal carcinoma of the pancreas. Pathol Int 63 : 415-418, 2013
PubMed
8) Ban S, Shimizu Y, Ogawa F et al : Reevaluation of "Cancerization of the Duct". Lab Invest 87 (Suppl 1) : 276A, 2007
 
9) 伴慎一, 山口浩, 清水道生 : 膵癌の病理. 外科治療 97 : 258-267, 2007
Medical*Online
10) 長谷川誠, 水谷和樹, 板津慶幸他 : 総胆管内に乳頭状に発育進展した膵頭部癌の1例. 日消外会誌 31 : 2260-2264, 1998
 
11) Adsay V, Logani S, Sarkar F et al : Foamy gland pattern of pancreatic ductal adenocarcinoma : a deceptively benignappearing variant. Am J Surg Pathol 24 : 493-504, 2000
PubMed
12) Albores-Saavedra J, Delgado R, Henson DE : Well-differentiated adenocarcinoma, gastric foveolar type, of the extrahepatic bile ducts : A previously unrecognized and distinctive morphologic variant of bile duct carcinoma. Ann Diagn Pathol 3 : 75-80, 1999
PubMed
13) Hruban RH, Adsay NV, Albores-Saavedra J et al : Pancreatic intraepithelial neoplasia : a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25 : 579-586, 2001
PubMed
14) Maitra A, Adsay NV, Argani P et al : Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16 : 902-912, 2003
PubMed
15) Zen Y, Aishima S, Ajioka Y et al : Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma : preliminary report based on interobserver agreement. Pathol Int 55 : 180-188, 2005
PubMed
16) Sato Y, Sasaki M, Harada K et al : Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia. J Gastroenterol 49 : 64-72, 2014
PubMed
17) 竹内真実子, 小屋敏也, 新井利幸他 : 興味深い膵浸潤様式を示した下部胆管癌の1例. 胆道 28 : 207-212, 2014
Medical*Online
P.210 掲載の参考文献
1) Nakanuma Y, Curado MP, Franceschi S et al : Intrahepatic cholangiocarcinoma. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO Classification of Tumors of the Digestive System", 4th ed, IARC Press, Lyon, 2010, pp217-224
 
2) 日本肝癌研究会 (編) : 臨床・病理 原発性肝癌取扱い規約, 第5版補訂版, 金原出版, 2009
 
3) 日本肝胆膵外科学会 (編) : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
4) Nakanuma Y, Sato Y, Ojima H et al : Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)". Int J Clin Exp Pathol 7 : 3112-3122, 2014
PubMed
5) Tanaka M, Fernandez-del Castillo C, Adsay V et al : International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12 : 183-197, 2012
PubMed
6) Albores-Saavedra J, Adsay NV, Craeford JM et al : Carcinoma of the gallbladder and extrahepatic bile ducts. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO Classification of Tumors of the Digestive System", 4th ed, IARC Press, Lyon, 2010, pp266-273
 
7) Onoe S, Shimoyama Y, Ebata T et al : Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion : A single-institution study with 184 patients. Surgery 155 : 280-291, 2014
PubMed
8) Adsay NV, Fukushima N, Furukawa T et al : Intraductal neoplasms of the pancreas. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO Classification of Tumors of the Digestive System", 4th ed, IARC Press, Lyon, 2010, pp304-313
 
9) Zen Y, Adsay NV, Bardadin K et al : Biliary intraepithelial neoplasia : an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 20 : 701-709, 2007
PubMed
10) Sato Y, Sasaki M, Harada K et al : Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia. J Gastroenterol 49 : 64-72, 2014
PubMed
11) Furukawa T, Kuboki Y, Tanji E et al : Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1 : 161, 2011
PubMed
12) Hsu M, Sasaki M, Igarashi S et al : KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer 119 : 1669-1674, 2013
PubMed
13) Sasaki M, Matsubara T, Nitta T et al : GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct. PLos One 8 : e81706, 2013
PubMed
P.216 掲載の参考文献
1) 日本胆道外科研究会編 : 外科・病理・胆道癌取扱い規約, 第6版, 金原出版, 2013
 
2) 須田耕一 : 十二指腸乳頭部の病理. 胆道 18 : 584-589, 2005
 
3) Lack E : Pathology of the extrahepatic biliary duct and ampullary region. Pathology of the pancreas, gallbladder, extrahepatic biliary duct and ampullary region. PART III Oxford university press, NY, 2003, pp511-524
 
4) Alnores-Saavedra J, Henson DE, Klimstra DS : Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of vater. in Rosai J, Sobin L (eds) : "Atlas of Tumor Pathology Third series, Fascicle 27", Armed Forces Institute of Pathology, Washington DC, 2000, pp245-258
 
5) 田尻琢磨, 楯玄秀, 大池信之 他 : 病理医が, 膵胆管生検に際し内視鏡医に望むこと. 消化器内視鏡 22 : 1055-1062, 2010
Medical*Online
6) Adsay NV, Ohike N, Tajiri T et al : Ampullary region carcinomas : Definition and site-specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol 36 : 1592-1608, 2012
 
7) Ohike N, KimGE, Tajiri T et al : Intra-ampullary papillarytubular neoplasm (IAPN) : characterization of tumoral intraepithelial neoplasia occurring within the ampulla : a clinicopathologic analysis of 82 cases. Am J Surg Pathol 34 : 1731-1748, 2010
PubMed
8) 田尻琢磨, 大池信之, Adsay NV他 : 乳頭部腫瘍と胆嚢腫瘍-十二指腸乳頭部腫瘍の概念および胆嚢前癌病変について-. 病理と臨床 31 : 245-253, 2013
 
9) 諸星利男, 国村利明, 大池信之他 : 胆道癌の病理像-とくに早期胆道癌の特徴について. 臨消内科 18 : 1089-1096, 2003
 
10) Albores-Saavedra J, Kloppel G, NV Adsay et al : Carcinoma of the gallbladder and extrahepatic bile ducts. in Hamilton SR, Aaltonen LA (eds) : "Pathology and genetics of tumours of the digestive system, World Health Organization classification of tumours", IARC Press, Lyon, France, 2010, pp 81-94
 
11) 鬼島宏, 渡辺英伸, 長村義之 : 胆道上皮の化生性変化と前癌病変の病理. 病理と臨床 21 : 31-41, 2003
Medical*Online
12) Yamaguchi H, Shimizu M, Ban S et al : Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 33 : 1164-1172, 2009
PubMed
13) Park HJ, Jang KT, Heo JS et al : A potential case of intraductal tubulopapillary neoplasms of the bile duct. Pathol Int 60 : 630-635, 2010
PubMed
14) Zen Y, Amarapurkar AD, Portmann BC : Intraductal tubulopapillary neoplasm of the bile duct : potential origin from peribiliary cysts Human Pathol 43 : 440-445, 2012
PubMed
15) Tajiri T, Tate G, Morohoshi T : Intraductal tubular carcinoma of the pancreas : -differential diagnosis and distinction from intraductal tubular adenoma. Pathol Case Review 15 : 199-204, 2010
 
16) Kasugai H, Tajiri T, Takehara Y et al : Intraductal tubulopapillary neoplasms of the pancreas : case report and review of the literature. JNMS 80 : 224-229, 2013
 
17) Tajiri T, Basturk O, Krasinskas A et al : Prognostic differences between ampullary carcinomas and pancreatic ductal carcinomas : the importance of size of invasive component (Abstract). Modern Pathology 22 : 323A, 2009
 
18) Adsay NV, Bagci P, Tajiri T et al : Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers : pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Seminar Diagn Pathol 29 : 127-141, 2012
 
19) Tajiri T, Ohike N, Balci S et al : Proposal for a More Applicable and Clinically Relevant Staging Evaluation of Ampullary Carcinomas (Abstract). Modern Pathology 24 : 169A, 2011
 
20) AJCC Cancer Staging Manual, 7th ed, Springer, New York, 2010, pp211-219
 
P.224 掲載の参考文献
1) Hulst SPL : Zur kenntnis der genese des adenokarzinoms und karzinoms des pankreas. Virchows Arch 180 : 288-316, 1905
 
2) Hruban RH, Adsay NV, Albores-Saavedra J et al : Pancreatic intraepithelial neoplasia : a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25 : 579-586, 2001
PubMed
3) Adsay NV, Fukushima N, Furukawa T et al : Intraductal neoplasms of the pancreas. in Bosman FT, Carneiro F, Hruban RH et al (eds) : "WHO Classification of Tumours of the Digestive System" (4th ed.), IARC Press, Lyons France, 2010, pp304-313
 
4) 日本膵臓学会編 : 膵癌取扱い規約, 第6版, 金原出版, 2009
 
5) Furukawa T, Kuboki Y, Tanji E et al : Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1 : 161, 2011 (Epub 2011 Nov 18)
 
6) Wu J, Matthaei H, Maitra A et al : Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 20 : 3 (92), 92ra66, 2011
 
7) Hruban RH, Takaori K, Klimstra DS et al : An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28 : 977-987, 2004
PubMed
8) 福嶋敬宜 : 膵管内乳頭粘液性腫瘍 (IPMN) と膵上皮内腫瘍性病変 (PanIN) の診断と意義. 病理と臨床 31 : 268-276, 2013
Medical*Online
P.229 掲載の参考文献
1) Furukawa T, Kloppel G, Volkan Adsay N et al : Classification of types of intraductal papillary-mucinous neoplasm of the pancreas : a consensus study. Virchows Arch 447 : 794-799, 2005
PubMed
2) Furukawa T, Hatori T, Fujita I et al : Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 60 : 509-516, 2011
PubMed
3) Yamaguchi K, Kanemitsu S, Hatori T et al : Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPM. Pancreas 40 : 571-580, 2011
 
4) 山口幸二, 金光秀一, 羽鳥隆他 : IPMN由来浸潤癌とIPMN併存膵癌. 膵臓 27 : 563-571, 2012
Medical*Online
5) Ideno N, Ohtsuka T, Kono H et al : Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 258 : 141-151, 2013
PubMed
6) Furukawa T, Kuboki Y, Tanji E et al : Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1 : 161, 2011
PubMed
7) Ohtsuka T, Kono H, Tanabe R et al : Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas ; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg 204 : 44-48, 2012
 
P.238 掲載の参考文献
1) 大池信之, 諸星利男 : 膵・消化管に発生する神経内分泌腫瘍. 病理と臨床 29 : 451-459, 2011
Medical*Online
2) 能登原憲司 : 胆膵の硬化性病変-自己免疫性膵炎を中心に- 病理と臨床 31 : 369-375, 2013
Medical*Online
P.244 掲載の参考文献
1) 古旗淳, 権田厚文, 安部佳之他 : 胆汁・膵液の細胞診. Medical Technology 33 : 1482-1489, 2005
 
2) 広岡保明, 中泉明彦, 岡輝明他 : 胆汁細胞診の採取・判定方法に関する研究 (第一報), 貯留胆汁細胞診の細胞判定基準. 日臨細胞誌 49 : 7-14, 2010
 
3) 中泉明彦, 竹中明美 : 膵液細胞診・擦過細胞診の判定基準と有用性. 病理と臨床 27 : 1157-1165, 2009
Medical*Online
4) Zaman MB : The pancreas. in Koss LG (ed) : "Koss's Diagnostic Cytology and its histopathologic bases", 5th ed, Lippincott WW, Philadelphia, 2006, pp1428-1456
 
5) Labate AM, Klimstra DL, Zakowski MF : Comparative cytologic features of pancreatic acinar cell carcinoma and islet cell tumor. Diagn cytopathol 16 : 112-116, 1997
PubMed
6) Hasegawa T, Yamao K, Hijioka S et al : Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors : Endoscopy 46 : 32-38, 2014
PubMed
7) Kashima K, Hayashida Y, Yokoyama S et al : Cytologic features of solid and cystic tumor of the pancreas. Acta Cytol 41 : 443-449, 1997
PubMed
8) Hibi Y, Fukushima N, Tsuchida A et al : Pancreatic juice cytology and subclassification of intraductal mucinous neoplasms of the pancreas. Pancreas 34 : 197-204, 2007
PubMed
P.250 掲載の参考文献
1) 清水康仁, 大塚将之, 伊藤博他 : 肝門部胆管癌切除症例における術中迅速病理診断による胆管十二指腸側断端評価の有用性. 胆道 18 : 182-188, 2004
Medical*Online
2) 鬼島宏 : 胆嚢・胆管. 向井清, 真鍋俊明, 深山正久編 : 外科病理学 I, 文光堂, 2006, pp688-690
 
3) Igami T, Nagino M, Oda K et al : Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249 : 296-302, 2009
PubMed
4) Ojima H, Kanai Y, Iwasaki M et al : Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 100 : 62-70, 2009
PubMed
5) Higuchi R, Ota T, Araida T et al : Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery 148 : 7-14, 2010
PubMed
6) Zen Y, Adsay NV, Bardadin K et al : Biliary intraepithelial neoplasia : an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 20 : 701-709, 2007
PubMed
7) 鬼島宏, 中沼安二 : 胆道における腫瘍類似病変にはどのようなものがあるか?. 日本肝胆膵外科学会胆道診療ガイドライン作成委員会編 : エビデンスに基づいた胆道癌診療ガイドライン, 医学図書出版, 2014, pp129-134
 
8) Ouchi K, Mikuni J, Kakugawa Y et al : Laparoscopic cholecystectomy for gallbladder carcinoma : results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg 9 : 256-260, 2002
PubMed
9) Kontozoglou TE, Cramer HM : The advantages of intraoperative cytology. Analysis of 215 smears and review of the literature. Acta Cytol 35 : 156-164, 1991
 
10) Tone K, Kojima K, Hoshiai K et al : Utility of intraoperative cytology of resection margins in biliary tract and pancreas tumors. Diagn Cytopahol 2014 Dec 4. doi : 10. 1002/dc. 23240 (in press)
 
P.256 掲載の参考文献
1) Millikan KW, Deziel DJ, Silverstein JC et al : Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65 : 618-623, 1999
PubMed
2) Maksymov V, Hogan M, Khalifa MA : An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment. HPB (Oxford) 15 : 218-223, 2013
PubMed
3) Adsay NV, Basturk O, Saka B et al : Whipple made simple for surgical pathologists : orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors. Am J Surg Pathol 38 : 480-493, 2014
PubMed
4) 木村理 : 膵癌の外科切除は神経浸潤との戦いか? 膵後方浸潤と膵頭神経叢浸潤. 膵臓 19 : 33-39, 2004
Medical*Online
5) Khalifa MA, Maksymov V, Rowsell CH et al : A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen. HPB (Oxford) 9 : 146-149, 2007
 
6) 木村理 : 膵頭十二指腸切除術における膵頭神経叢切除の理論と方法. 外科解剖・病理からみた提言. 膵臓 19 : 463-470, 2004
Medical*Online
7) Kooby DA, Lad NL, Squires MH 3rd et al : Value of intraoperative neck margin analysis during whipple for pancreatic adenocarcinoma : a multicenter analysis of 1399 patients. Ann Surg 260 : 494-501, 2014
PubMed
8) Hernandez J, Mullinax J, Clark W et al : Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 250 : 76-80, 2009
PubMed
9) Lad NL, Squires MH, Maithel SK et al : Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy? Ann Surg Oncol 20 : 3626-3633, 2013
PubMed
10) Mathur A, Ross SB, Luberice K et al : Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued. Am Surg 80 : 353-360, 2014
 
11) Tanaka M, Fernandez-del Castillo C, Adsay V et al : International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12 : 183-197, 2012
PubMed

第4部 臨床との連携

P.269 掲載の参考文献
1) 西尾秀樹, 梛野正人, 江畑智希他 : 手術適応基準から考える胆道癌の読影ポイント. 画像診断 26 : 544-553, 2006
 
2) 蒲田敏文, 松井修, 山城正司 : 肝門部胆管癌のMD-CTによる診断. 胆道専門医講座 外科医が求める診断. 胆道 21 : 204-214, 2007
 
3) Katabathina VS, Dasyam AK, Dasyam N et al : Adult bile duct strictures ; role of MR cholangiopancreatography in characterization. RadioGraphics 34 : 565-586, 2014
PubMed
4) 竹原康雄, 高橋護 : 胆道癌 (肝外胆道) の画像診断. MRIによる胆道癌術前評価と診断. 臨床画像 24 : 1109-1119, 2008
 
5) 全陽, 中沼安二 : 膵・胆道系腫瘍のトピックス 粘液産生性腫瘍を中心に. 胆道粘液産生性腫瘍の病理診断. 病理と臨床 27 : 546-553, 2009
 
6) 小坂一斗, 蒲田敏文, 小林聡他 : IPNBの画像診断と粘液産生. 粘液産生性胆道系腫瘍の再出発-エビデンスとしての画像と病理. 胆と膵 34 : 381-387, 2013
 
7) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
8) Catalano OA, Sahani DV, Kalva SP et al : MR Imaging of the Gallbladder : A Pictorial Essay. RadioGraphics 28 : 135-155, 2008
PubMed
9) Kim BS, Ha HK, Lee IJ et al : Accuracy of CT in local staging of gallbladder carcinoma. Acta Radiol 43 : 71-76, 2002
PubMed
10) Li B, Xu XX, Du Y et al : Computed tomography for assessing respectability of gallbladder carcinoma : a systematic review and meta-analysis. Clin Imaging 37 : 327-333, 2013
 
11) 小山内学, 真口宏介, 浦田孝広他 : 胆嚢管癌8切除例の臨床像と画像診断. 胆道 20 : 17-25, 2006
Medical*Online
12) Fukukura Y, Hamada H, Kamiyama T et al : Pancreatic adenocarcinoma : analysis of the effect of various concentration of contrast material. Radiation Medicine 26 : 355-361, 2008
PubMed
13) Mochizuki K, Gabata T, Kazuto K et al : MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma : correlation with en bloc pathological sepecimens and diagnostic accuracy. Eur Radiol 20 : 1757-1767, 2010
 
14) 北川裕久, 蒲田敏文, 大坪公士郎 : 膵癌診療アトラス-画像と病理の対比から学ぶ-, 秀潤社, 2012, pp85-168
 
15) Mehmet ES, Ichikawa T, Sou H et al : Pancreatic adenocarcinoma : MDCT versus MRI foe detecting and assessment of local extension. J Comput Assist Tomogr 30 : 583-590, 2006
 
16) 蒲田敏文 : 膵. 荒木力編 : 腹部のMRI, 第3版, メディカル・サイエンス・インターナショナル, 2014, pp181-222
 
17) Gabata T, Matsui M, Kadoya M et al : Small pancreatic carcinomas : efficacy MR imaging with fat suppression and gadolinium enhancement. Radiology 193 : 683-688, 1994
 
18) Ichikawa T, Erturk SM, Motosugi Y et al : High-b valueweighted MRI for detecting pancreatic adenocarcinoma : preliminary results. AJR 188 : 409-414, 2007
 
P.280 掲載の参考文献
1) Hewitt MJ, McPhail MJ, Possmai L et al : EUS-guided FNA for diagnosis of solid pancreatic neoplasms : a metaanalysis. Gastrointest Endosc 75 : 319-331, 2012
 
2) Osanai M, Itoi T, Igarashi Y et al : Peroral video cholangioscopy to evaluate indeterminate bile duct lesions and preoperative mucosal cancerous extension : a prospective multicenter study. Endoscopy 45 : 635-642, 2013
PubMed
3) Itoi T, Sofuni A, Itokawa F et al : Initial experience of peroral pancreatoscopy combined with narrow-band imaging in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas (with videos). Gastrointest Endosc 66 : 793-797, 2007
PubMed
4) 土屋貴愛, 糸井隆夫, 祖父尼淳他 : 膵臓の内視鏡検査のスタンダード. 肝胆膵 69 : 223-236, 2014
Medical*Online
5) 原田昇, 神津照雄, 大島郁也 他 : 超音波内視鏡下穿刺法の基礎的研究 (第1報). Gastroenterol Endosc 33 : 1657-1661, 1991
 
6) Vilmann P, Jacobsen GK, Henriken FW et al : Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 38 : 172-173, 1992
 
7) Hewitt MJ, McPhail MJ, Possamai L et al : EUS-guided FNA for diagnosis of solid pancreatic neoplasms : a metaanalysis. Gastrointest Endosc 75 : 319-331, 2012
PubMed
8) Itoi T, Tsuchiya T, Itokawa F et al : Histological diagnosis by EUS-guided fine-needle aspiration biopsy in pancreatic solid masses without on-site cytopathologist : a singlecenter experience. Dig Endosc23 (Suppl 1) : 34-38, 2011
 
9) 土屋貴愛, 糸井隆夫, 祖父尼淳他 : 胆道癌の診断. 臨床外科 67 : 186-197, 2012
 
10) 潟沼朗生, 真口宏介, 金俊文 : 胆道癌の超音波診断. コンセンサス癌治療 8 : 14-17, 2009
 
11) 小山内学, 真口宏介, 糸川文英他 : TS-1膵癌における各種画像検査の診断能と診断方策. 胆と膵 26 : 507-513, 2005
Medical*Online
12) De Witt J, Devereaux B, Chriswell M et al : Comparison of endoscopic ultrasonography and multiditector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141 : 753-763, 2004
 
13) 日本膵臓学会膵癌診療ガイドライン改訂委員会編 : 膵癌診療ガイドライン 2013年版, 金原出版, 2013
 
14) 川井俊郎, 藤井丈二, 石田晶子他 : 胆嚢病変に対する胆汁細胞診の陽性率に関する因子について. 日臨細胞会誌 38 : 299-304, 1999
 
15) Itoi T, Sofuni A, Itokawa F et al : Preoperative diagnosis and management of thick-walled gallbladder based on bile cytology obtained by endoscopic transpapillary gallbladder drainage tube. Gastrointest Endosc 64 : 512-519, 2006
PubMed
16) 栗原俊夫, 糸井隆夫, 祖父尼淳他 : 胆汁細胞診の正診率を上げるために. 胆と膵 29 : 709-715, 2008
Medical*Online
17) Khan SA, Thomas HC, Davidson BR et al : Cholangiocarcinoma. Lancet 366 : 1303-1314, 2005
PubMed
18) Itoi T, Sofuni A, Itokawa F et al : Peroral cholangioscopic diagnosis of biliary tract diseases using a narrow-band imaging (with video). Gastrointest Endosc 66 : 730-736, 2007
PubMed
19) Kawakami H, Kuwatani M, Etoh K et al : Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy 41 : 959-964, 2009
PubMed
P.289 掲載の参考文献
1) 胆道癌診療ガイドライン作成委員会編 : エビデンスに基づいた胆道癌診療ガイドライン, 改訂第2版, 医学図書出版, 2014
 
2) 日本膵臓学会 膵癌診療ガイドライン改訂委員会編 : 科学的根拠に基づく膵癌診療ガイドライン 2013年版, 金原出版, 2013
 
3) 日本肝胆膵外科学会編 : 臨床・病理胆道癌取扱い規約, 第6版, 金原出版, 2013
 
4) Sobin LG, Gospodarowicz MK, Wittekind Ch eds : TNM classification of malignant tumors (7th ed.), Wiley-Blackwell, New York, 2010
 
5) Klempnauer J, Ridder GJ, von Wasielewski R et al : Resectional surgery of hilar cholangiocarcinoma : a multivariate analysis of prognostic factors. J Clin Oncol 15 : 947-954, 1997
PubMed
6) Kosuge T, Yamamoto J, Shimada K et al : Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230 : 663-671, 1999
PubMed
7) Nimura Y, Kamiya J, Kondo S et al : Aggressive preoperative management and extended surgery for hilar cholana giocarcinoma : Nagoya experience. J Hepatobiliary Pancreat Surg 7 : 155-162, 2000
 
8) Bhuiya MR, Nimura Y, Kamiya J et al : Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 215 : 344-349, 1992
PubMed
9) Sano T, Shimada K, Sakamoto Y et al : Prognosis of perihilar cholangiocarcinoma : Hilar bile duct cancer versue intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol 15 : 590-599, 2007
 
10) Wakai T, Shirai Y, Moroda T et al : Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 103 : 1210-1216, 2005
PubMed
11) Kondo S, Hirano S, Ambo Y, et al : Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins : results of a prospective study. Ann Surg 240 : 95-101, 2004
PubMed
12) Kayahara M, Nagakawa T, Ohta T et al : Role of nodal involvement and the periductal softtissue margin in middle and distal bile duct cancer. Ann Surg 229 : 76-83, 1999
PubMed
13) Sakamoto Y, Kosuge T, Shimada K et al : Prognostic factors of surgical resection in middle and distal bile duct cancer : An analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 137 : 396-402, 2005
PubMed
14) Cheng Q, Luo X, Zhang B et al : Distal bile duct carcinoma : prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol 14 : 1212-1219, 2007
PubMed
15) Wakai T, Shirai Y, Tsuchiya Y et al : Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma : Long-term results. World J Surg 32 : 1067-1074, 2008
PubMed
16) Jang JY, Kim SW, Lee SE et al : Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer. Ann Surg 250 : 943-949, 2009
PubMed
17) Sakamoto Y, Kosuge T, Shimada K et al : Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol 94 : 298-306, 2006
PubMed
18) Kishi Y, Shiamda K, Hata S et al : Definition of T3/4 and regional lymph nodes in gallbladder Cancer : Which is more valid, the UICC or the Japanese staging system? Ann Surg Oncol 19 : 3567-3573, 2012
 
19) Shimada K, Nara S, Esaki M et al : Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. Br J Surg 98 : 117-123, 2011
PubMed
20) 堀周太郎, 島田和明, 岸庸二他 : 胆道癌として外科切除された鑑別困難病変の検証-画像と病理所見の対比-, 術前胆嚢癌疑いにて外科切除された良性病変の検討. 胆と膵 35 : 291-297, 2014
 
21) Shirai Y, Yoshida K, Tsukada K et al : Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 215 : 326-331, 1992
PubMed
22) Nakagawa T, Kayahara M, Ikeda S et al : Biliary tract cancer treatment : results from the biliary tract cancer statistics registry in Japan. J Hepatobiliary Pancreat Surg 9 : 569-575, 2002
 
23) 日本膵臓学会編 : 膵癌取扱い規約, 第6版補訂版, 金原出版, 2013
 
24) Prokwsch RW, Chow LC, Beaulieu CF et al : Isoattenuating pancreatic adenocarcinoma at multi-detector row CT : secondary signs. Radiology 224 : 764-768, 2002
 
25) Shimada K, Sakamoto Y, Nara S et al : Analysis of 5-Year survivors after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma. World J Surg 34 : 1908-1915, 2010
PubMed
26) Calley MP, Chang KJ, Fishman EK et al : Pretreatment assessment of resectable and borderline resectable pancreatic cancer : Expert consensus statement. Ann Surg Oncol 16 : 1727-1733, 2009
 
27) 島田和明, 奈良聡, 江崎稔他 : 特集 膵癌updae 2012 II. 診断 3. 膵癌診断におけるMDCT, MRI, FDG-PETの役割-MDCTを中心とした術前画像診断. 外科 74 : 491-500, 2012
 
28) Strasberg SM, Drebin JA, Linehan D : Radical antegrade modular pancreatosplenectomy. Surgery 133 : 521-527, 2003
PubMed
29) Hirano S, Kondo S, Tanaka E et al : Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer : long-term results. Ann Surg 246 : 46-51, 2007
PubMed
P.303 掲載の参考文献
1) 日本肝胆膵外科学会 胆道癌診療ガイドライン作成委員会編 : エビデンスに基づいた胆道癌診療ガイドライン, 第2版, 医学図書出版, 2014
 
2) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
3) Lack EE : Pathology of the pancreas, gallbladder, extrahepatic biliary tract, and ampullary region. Oxford University Press, New York, 2003
 
4) Kubota K, Bandai Y, Noie T, et al : How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery 117 : 481-487, 1995
PubMed
5) Yamaguchi K, Enjoji M, Kitamura K : Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 36 : 588-592, 1990
PubMed
6) Itoi T, Sofuni A, Itokawa F et al : Preoperative diagnosis and management of thick-walled gallbladder based on bile cytology obtained by endoscopic transpapillary gallbladder drainage tube. Gastrointest Endosc 64 : 512-519, 2006
PubMed
7) Wu LM, Jiang XX, Gu HY et al : Endoscopic ultrasoundguided fine-needle aspiration biopsy in the evaluation of bile duct strictures and gallbladder masses : a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 23 : 113-120, 2011
PubMed
8) Yamamoto H, Hayakawa N, Kitagawa Y et al : Unsuspected gallbladder carcinoma after laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg 12 : 391-398, 2005
PubMed
9) Ebata T, Watanabe H, Ajioka Y et al : Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 89 : 1260-1267, 2002
PubMed
10) Igami T, Nagino M, Oda K et al : Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249 : 296-302, 2009
PubMed
11) Wakai T, Shirai Y, Moroda T et al : Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 103 : 1210-1216, 2005
PubMed
12) Sasaki R, Takeda Y, Funato O et al : Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg 31 : 1788-1796, 2007
PubMed
13) Ojima H, Kanai Y, Iwasaki M et al : Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 100 : 62-70, 2009
PubMed
14) Nakanishi Y, Kondo S, Zen Y et al : Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci 17 : 166-173, 2010
PubMed
15) Higuchi R, Ota T, Araida T et al : Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery 148 : 7-14, 2010
PubMed
P.308 掲載の参考文献
1) 日本膵臓学会膵癌診療ガイドライン改訂委員会編 : 科学的根拠に基づく膵癌診療ガイドライン 2013年版, 金原出版, 2013
 
2) 日本膵臓学会編 : 膵癌取扱い規約, 第6版補訂版, 金原出版, 2009
 
3) Ueno H, Kosuge T, Matsuyama Y et al : A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer : Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 101 : 908-915, 2009
 
4) Stocken DD, Buchler MW, Dervenis C et al : Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92 : 1372-1381, 2005
PubMed
5) Tanaka M, Fernandez-del Castillo C, Adsay V et al : International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12 : 183-197, 2012
PubMed
6) Tanno S, Nakano Y, Sugiyama Y et al : Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 10 : 173-178, 2010
PubMed
7) Adsay NV, Merati K, Andea A et al : The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas : differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 15 : 1087-1095, 2002
PubMed
8) Hibi Y, Fukushima N, Tsuchida A et al : Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 34 : 197-204, 2007
PubMed
9) 日本神経内分泌腫瘍研究会編 : 膵・消化管神経内分泌腫瘍 (NET) 診療ガイドライン, 第1版, 2013 http://jnets.umin.jp/pdf/guideline001.pdf
 
10) Klimstra DS, Arnold R, Capella C et al : Neuroendocrine neoplasms of the pancreas. in Bosman FT, Hruban RH, Carneiro F et al (eds) : "WHO classification of Tumors of the digestive system" (4th ed.), World Health Organization Classification of Tumor, WHO Press, Geneva, 2010, pp322-326
 
11) Aparicio T, Ducreux M, Baudin E et al : Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours. Eur J Cancer 37 : 1014-1019, 2001
PubMed
P.312 掲載の参考文献
1) Evans DB, Rich TA, Byrd DR et al : Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinaoma of the pancreas. Arch Surg 127 : 1335-1339, 1992
 
2) Chun YS, Cooper HS, Cohen SJ et al : Significance of pathologic response to preoperative therapy in pancreatic cancer. Ann Surg Oncol 18 : 3601-3607, 2011
PubMed
3) Shimosato Y, Oboshi S, Baba K : Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jap J Clin Oncol 1 : 19-35, 1971
 
4) 日本乳癌学会編 : 臨床・病理 乳癌取扱い規約, 第17版, 金原出版, 2012
 
P.317 掲載の参考文献
1) Bosman FT, Carneiro F, Hruban RH et al (eds) : WHO Classification, Tumours of the Digestive System, 4th ed, IARC Press, Lyon, 2010
 
2) 日本膵臓学会編 : 膵癌取扱い規約, 第6版補訂版, 金原出版, 2013
 
3) 日本肝胆膵外科学会編 : 臨床・病理 胆道癌取扱い規約, 第6版, 金原出版, 2013
 
P.321 掲載の参考文献
1) Pitman MB, Centeno BA, Ali SZ, et al : Standardized terminology and nomenclature for pancreatobiliary cytology : the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol 42 : 338-350, 2014
PubMed
2) Tanaka M, Fernandez-del Castillo C, Adsay V et al : International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12 : 183-197, 2012
PubMed
3) Martin RC, Klimastra DS, Brennan MP et al : Solid-pseudopapillary tumor of the pancreas : a surgical enigma? Ann Surg Oncol 9 : 35-40, 2002
 

書評

最近チェックした商品履歴

Loading...